- Home
- IBRX vs AZZ Comparison
IBRX vs AZZ Comparison
Compare IBRX & AZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBRX
- AZZ
- Stock Information
- Founded
- IBRX 2014
- AZZ 1956
- Country
- IBRX United States
- AZZ United States
- Employees
- IBRX N/A
- AZZ N/A
- Industry
- IBRX Biotechnology: Biological Products (No Diagnostic Substances)
- AZZ Industrial Specialties
- Sector
- IBRX Health Care
- AZZ Industrials
- Exchange
- IBRX Nasdaq
- AZZ Nasdaq
- Market Cap
- IBRX 2.4B
- AZZ 2.7B
- IPO Year
- IBRX N/A
- AZZ N/A
- Fundamental
- Price
- IBRX $2.06
- AZZ $91.18
- Analyst Decision
- IBRX Strong Buy
- AZZ Strong Buy
- Analyst Count
- IBRX 5
- AZZ 8
- Target Price
- IBRX $11.35
- AZZ $100.71
- AVG Volume (30 Days)
- IBRX 8.8M
- AZZ 247.2K
- Earning Date
- IBRX 05-16-2025
- AZZ 04-21-2025
- Dividend Yield
- IBRX N/A
- AZZ 0.75%
- EPS Growth
- IBRX N/A
- AZZ N/A
- EPS
- IBRX N/A
- AZZ 1.79
- Revenue
- IBRX $14,745,000.00
- AZZ $1,577,744,000.00
- Revenue This Year
- IBRX $579.28
- AZZ $7.56
- Revenue Next Year
- IBRX $179.96
- AZZ $3.06
- P/E Ratio
- IBRX N/A
- AZZ $50.71
- Revenue Growth
- IBRX 2270.58
- AZZ 2.61
- 52 Week Low
- IBRX $1.83
- AZZ $69.59
- 52 Week High
- IBRX $9.16
- AZZ $99.49
- Technical
- Relative Strength Index (RSI)
- IBRX 36.89
- AZZ 61.65
- Support Level
- IBRX $1.83
- AZZ $86.88
- Resistance Level
- IBRX $2.17
- AZZ $91.85
- Average True Range (ATR)
- IBRX 0.18
- AZZ 3.08
- MACD
- IBRX -0.05
- AZZ 0.83
- Stochastic Oscillator
- IBRX 23.56
- AZZ 95.29
About IBRX ImmunityBio Inc.
ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.
About AZZ AZZ Inc.
AZZ Inc is a provider of galvanizing and a variety of metal coating solutions and coil coating solutions to a broad range of end markets in North America. In its Metal Coatings segment, the company offers metal finishing services to protect against corrosion, such as hot dip galvanizing, spin galvanizing, powder coating, anodizing, and plating. The Precoat Metals Segment offers aesthetic and corrosion-resistant coatings for steel and aluminum coils.